In vivo screen of genetically conserved Streptococcus pneumoniae proteins for protective immunogenicity (Q39212752)

10 September 2017

title

In vivo screen of genetically conserved Streptococcus pneumoniae proteins for protective immunogenicity (English)

1 reference

10 September 2017

main subject

Streptococcus pneumoniae

object named as

Streptococcus pneumoniae

1 reference

Richard J Anderson

1 reference

10 September 2017

Siradanahalli Guru

1 reference

10 September 2017

Risini Weeratna

1 reference

10 September 2017

Shawn Makinen

1 reference

10 September 2017

Derek J Falconer

1 reference

10 September 2017

Neil C Sheppard

1 reference

10 September 2017

Susanne Lang

1 reference

10 September 2017

Bingsheng Chang

1 reference

10 September 2017

Anne-Laure Goenaga

1 reference

10 September 2017

Bruce A Green

1 reference

10 September 2017

James R Merson

1 reference

10 September 2017

Stephen J Gracheck

1 reference

10 September 2017

Jim E Eyles

1 reference

10 September 2017

language of work or name

English

0 references

publication date

2 November 2016

1 reference

10 September 2017

1 reference

10 September 2017

1 reference

10 September 2017

1 reference

10 September 2017

page(s)

6292-6300

1 reference

Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.061

The pneumococcus: epidemiology, microbiology, and pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.061

Development and clinical evaluation of Prevnar 13, a 13-valent pneumocococcal CRM197 conjugate vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.061

Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.061

Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on vaccine-type invasive pneumococcal disease among young children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.061

New conjugate vaccines for the prevention of pneumococcal disease in developing countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.061

Correlates of protection induced by vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.061

Challenges in the evaluation and licensing of new pneumococcal vaccines, 7-8 July 2008, Ottawa, Canada

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.061

Issues and challenges in the development of pneumococcal protein vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.061

Review: current and new generation pneumococcal vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.061

Preclinical Evaluation of the Pht Proteins as Potential Cross-Protective Pneumococcal Vaccine Antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.061

Safety and immunogenicity of an investigational vaccine containing two common pneumococcal proteins in toddlers: a phase II randomized clinical trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.061

Pneumococcal histidine triad proteins are regulated by the Zn2+-dependent repressor AdcR and inhibit complement deposition through the recruitment of complement factor H.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.061

Transcriptional regulation, occurrence and putative role of the Pht family of Streptococcus pneumoniae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.061

Role of Pht proteins in attachment of Streptococcus pneumoniae to respiratory epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.061

Sortase A confers protection against Streptococcus pneumoniae in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.061

Streptococcus pneumoniae protein vaccine candidates: properties, activities and animal studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.061

Analysis of Structure and Function of Putative Surface-Exposed Proteins Encoded in theStreptococcus pneumoniaeGenome: A Bioinformatics-Based Approach to Vaccine and Drug Design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.061

Recombinant PhpA protein, a unique histidine motif-containing protein from Streptococcus pneumoniae, protects mice against intranasal pneumococcal challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.061

Approach to validating an opsonophagocytic assay for Streptococcus pneumoniae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.061

Use of a whole genome approach to identify vaccine molecules affording protection against Streptococcus pneumoniae infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.061

Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.061

Live attenuated influenza vaccine enhances colonization of Streptococcus pneumoniae and Staphylococcus aureus in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.061

Microbiological and inflammatory factors associated with the development of pneumococcal pneumonia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.061

The cell wall-associated serine protease PrtA: a highly conserved virulence factor of Streptococcus pneumoniae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.061

Immune response to capsular polysaccharide and surface proteins of Streptococcus pneumoniae in patients with invasive pneumococcal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.061

The substrate specificity of the enzyme endo-alpha-N-acetyl-D-galactosaminidase from Diplococcus pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.061

Deglycosylation of human glycoconjugates by the sequential activities of exoglycosidases expressed by Streptococcus pneumoniae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.061

Pneumococcal neuraminidase A: an essential upper airway colonization factor for Streptococcus pneumoniae.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.061

Pneumococcal neuraminidases A and B both have essential roles during infection of the respiratory tract and sepsis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.061

Immunization with recombinant Streptococcus pneumoniae neuraminidase NanA protects chinchillas against nasopharyngeal colonization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.061

Pneumococcal microbial surface components recognizing adhesive matrix molecules targeting of the extracellular matrix.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.061

PavB is a surface-exposed adhesin of Streptococcus pneumoniae contributing to nasopharyngeal colonization and airways infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.061

Animal models of Streptococcus pneumoniae disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.061

Streptococcus pneumoniae surface protein PcpA elicits protection against lung infection and fatal sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.061

Identification and characterization of a novel family of pneumococcal proteins that are protective against sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.061

Peritoneal culture alters Streptococcus pneumoniae protein profiles and virulence properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.061

The Streptococcus pneumoniae capsule inhibits complement activity and neutrophil phagocytosis by multiple mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.061

Immunization with components of two iron uptake ABC transporters protects mice against systemic Streptococcus pneumoniae infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.061

Relationship between surface accessibility for PpmA, PsaA, and PspA and antibody-mediated immunity to systemic infection by Streptococcus pneumoniae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.061

Protection of mice against fatal pneumococcal challenge by immunization with pneumococcal surface adhesin A (PsaA).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.061

Involvement of potD in Streptococcus pneumoniae polyamine transport and pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.061

The pavA gene of Streptococcus pneumoniae encodes a fibronectin-binding protein that is essential for virulence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.061

Peptidoglycan N-acetylglucosamine deacetylase, a putative virulence factor in Streptococcus pneumoniae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.061

The streptococcal lipoprotein rotamase A (SlrA) is a functional peptidyl-prolyl isomerase involved in pneumococcal colonization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.061

Three surface exoglycosidases from Streptococcus pneumoniae, NanA, BgaA, and StrH, promote resistance to opsonophagocytic killing by human neutrophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.061

PppA, a surface-exposed protein of Streptococcus pneumoniae, elicits cross-reactive antibodies that reduce colonization in a murine intranasal immunization and challenge model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.061

10.1016/J.VACCINE.2016.10.061

7 January 2021

Identifiers

DOI

1 reference

10 September 2017

1 reference